By consistent I mean at the FDA it appears that perhaps each district office is inspecting and writing compounding pharmacies up in an inconsistent manner. For example, while a pharmacy in Oklahoma might be violating the rules and regulations in the same manner as a pharmacy in South Carolina, the one in South Carolina gets cited for the violation while the one in Oklahoma does not. Do the inspectors have a clear understanding of all the issues they should be looking for at each compounding pharmacy? Did they all receive the same training?
No comments:
Post a Comment